Development of an amorphous based sustained release system for apremilast a selective phosphodiesterase 4 (PDE4) inhibitor
Announcement
MySTYL'One
March 28, 2022
The present work details the development of an ASD based sustained-release (SR) drug delivery system. Full paper available in the PAPERS section.
Find others papers here and learn about
- Impact of Incorporated Drugs on Material Properties of Amorphous Solid Dispersions
- Effect of Polymers and Drug Loadings on the Performance of Itraconazole Spray- dried Dispersions (SDDs)
- Amorphous-based controlled-release gliclazide matrix system
#Dynamic mechanical analysis #Armophous system #Polymers #Micro-dissolution #Spray drying #apremilast #sustained release